These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 11710442)

  • 21. [Extrapyramidal complications during treatment with chlorpromazine and reserpine: clinical and electromyographic study].
    Delay J; Deniker P; Bourguignon A; Lempérière T
    Vertex; 2005; 16(64):469-72. PubMed ID: 16314902
    [No Abstract]   [Full Text] [Related]  

  • 22. Imipramine-induced hyperpigmentation of the skin.
    Mehr N; Wu JJ; Dyson SW; Woseth DM
    Dermatol Online J; 2007 Oct; 13(4):8. PubMed ID: 18319005
    [No Abstract]   [Full Text] [Related]  

  • 23. Dorsal hand skin hyperpigmentation following oral olanzapine (Zyprexa) use.
    Cary JH; Li BS; Maibach HI
    Contact Dermatitis; 2018 Oct; 79(4):254-255. PubMed ID: 30079483
    [No Abstract]   [Full Text] [Related]  

  • 24. Intraoperative floppy-iris syndrome associated with chronic use of chlorpromazine.
    Unal M; Yücel I; Tenlik A
    Eye (Lond); 2007 Sep; 21(9):1241-2. PubMed ID: 17603467
    [No Abstract]   [Full Text] [Related]  

  • 25. [Drug-induced laryngospasm].
    Nishikawa T; Munakata K
    Masui; 1997 Feb; 46(2):276-8. PubMed ID: 9071116
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heroin use, diplopia, largactil.
    Iqbal N
    Saudi Med J; 2000 Dec; 21(12):1194. PubMed ID: 11360100
    [No Abstract]   [Full Text] [Related]  

  • 27. Symptomatic antiphospholipid syndrome induced by chlorpromazine.
    Lillicrap MS; Wright G; Jones AC
    Br J Rheumatol; 1998 Mar; 37(3):346-7. PubMed ID: 9566684
    [No Abstract]   [Full Text] [Related]  

  • 28. Bilateral gynaecomastia in a Nigerian patient with schizophrenia.
    Coker AO
    Afr J Psychiatry (Johannesbg); 2010 May; 13(2):96. PubMed ID: 20473469
    [No Abstract]   [Full Text] [Related]  

  • 29. Systemic uptake of chlorpromazine after delivery via retrobulbar injection.
    Kuruvilla R; Sahu PD; Meltzer MA
    Arch Ophthalmol; 2012 Oct; 130(10):1348-9. PubMed ID: 23044961
    [No Abstract]   [Full Text] [Related]  

  • 30. Neuroleptic-associated catatonic reaction.
    Dorevitch A; Gabbay F
    Clin Pharm; 1983; 2(6):581-2. PubMed ID: 6140097
    [No Abstract]   [Full Text] [Related]  

  • 31. Facial hyperpigmentation. amiodarone-induced hyperpigmentation.
    e Silva LP; Luís F; Cabrera H
    Am Fam Physician; 2008 Dec; 78(11):1297-8. PubMed ID: 19069023
    [No Abstract]   [Full Text] [Related]  

  • 32. Hypogammaglobulinemia during antipsychotic therapy.
    Abe S; Suzuki T; Hori T; Baba A; Shiraishi H
    Psychiatry Clin Neurosci; 1998 Feb; 52(1):115-7. PubMed ID: 9682944
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Persistent chlorpromazine deposits in donor corneal tissue after corneal transplantation.
    Cahane M; Chen V; Avni I
    Cornea; 1997 Sep; 16(5):588-9. PubMed ID: 9294694
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Acute dyskinetic syndrome during chloropromazine treatment of a female patient with CYP2D6 poor metabolism phenotype].
    Beszłej JA; Grzesiak M; Milejski P
    Psychiatr Pol; 2007; 41(4):495-501. PubMed ID: 18046980
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chlorpromazine-induced refractile corneal deposits and cataract.
    Leung AT; Cheng AC; Chan WM; Lam DS
    Arch Ophthalmol; 1999 Dec; 117(12):1662-3. PubMed ID: 10604679
    [No Abstract]   [Full Text] [Related]  

  • 36. [Chlorpromazine-induced agranulocytosis: a case report].
    Stephan F; Podlipski MA; Kerleau JM; Petit M; Guillin O
    Encephale; 2009 Apr; 35(2):173-5. PubMed ID: 19393387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Agranulocytosis in the course of phenothiazine therapy: case reports.
    Yassa R
    J Clin Psychiatry; 1985 Aug; 46(8):341-3. PubMed ID: 2862136
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Neuroleptic drugs and trophic disorders].
    Vitorović M; Kobalova M
    Nervenarzt; 1984 Jan; 55(1):51-3. PubMed ID: 6143272
    [No Abstract]   [Full Text] [Related]  

  • 39. Neuroleptic malignant syndrome: three episodes with different drugs.
    Lavie CJ; Ventura HO; Walker G
    South Med J; 1986 Dec; 79(12):1571-3. PubMed ID: 2878496
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Withdrawal symptoms after long-term treatment with low-potency neuroleptics.
    Chouinard G; Bradwejn J; Annable L; Jones BD; Ross-Chouinard A
    J Clin Psychiatry; 1984 Dec; 45(12):500-2. PubMed ID: 6150030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.